3-METHYL-7-PROPYLXANTHINE

3-Methyl-7-propylpurine-2,6-dione; 3,7-Dihydro-3-methyl-7-propyl-1H-purine-2,6-dione; 3-Methyl-7-propylxanthine;

3-METHYL-7-PROPYLXANTHINE
 

PRODUCT IDENTIFICATION

CAS RN

55242-64-3

EINECS RN

 

FORMULA

 C9H12N4O2

MOLE WEIGHT

 208.22

H.S CODE

 2933.99.9700

SMILES

 CCCN1C=NC2=C1C(=O)NC(=O)N2C

CLASSIFICATION

Purine Alkaloid

EXTRA NOTES

  

 

PHYSICAL AND CHEMICAL PROPERTIES

PHYSICAL STATE

slightly yellow crystalline powder

MELTING POINT

  

BOILING POINT

  

DENSITY

  

SOLUBILITY IN WATER

  

VAPOR DENSITY

 
pH  

REFRACTIVE INDEX

  

FLASH POINT

 

 
STABILITY AND REACTIVITY
STABILITY Stable under normal conditions.

INCOMPATIBLE MATERIALS

 Strong oxidizing agents
DECOMPOSITION PRODUCTS

Carbon oxides, Nitrogen Oxides
POLYMERIZATION Has not been reported

NFPA RATINGS

Health Hazard: 1, Fire: 0, Reactivity Hazard: 0

 

EXTERNAL LINKS & GENERAL DESCRIPTION

Wikipedia Linking - Xanthine

Google Scholar Search

Drug Information Portal (U.S. National Library of Medicine) - 3-Methyl-7-propylxanthine

PubChem Compound Summary - 3-Methyl-7-propylxanthine

Drug Bank -  3-Methyl-7-propylxanthine

KEGG (Kyoto Encyclopedia of Genes and Genomes) -  3-Methyl-7-propylxanthine

http://www.ebi.ac.uk/chebi/ -  3-Methyl-7-propylxanthine

http://www.ncbi.nlm.nih.gov/ -  3-Methyl-7-propylxanthine

Human Metabolome Database - 3-Methyl-7-propylxanthine

http://www.sciencedirect.com/
The methylxanthine caffeine has many pharmacological effects, most of which can be linked to blockade of adenosine receptors, inhibition of phosphodiesterases, and augmentation of calcium-dependent release of calcium from intracellular stores. A variety of xanthines have been developed as potent and/or selective antagonists for adenosine receptors. Several xanthines have been developed that are more potent and more selective inhibitors of cyclic nucleotide phosphodiesterase than caffeine or theophylline. Caffeine remains the xanthine of choice for activation of intracellular calcium-sensitive calcium release channels although millimolar concentrations are required, which can have effects on other aspects of calcium regulation.

 

SALES SPECIFICATION

APPEARANCE

slightly yellow crystalline powder

ASSAY

96.0% min

 

TRANSPORT & REGULATORY INFORMATION

UN NO.

 Not regulated

HAZARD SYMBOL

 
PACKING GROUP

 

 

SAFETY INFORMATION

HAZARD OVERVIEW

 Not known
EC DIRECTIVES

 
HAZARD CODES

Xi Irritant

RISK PHRASES

 

SAFETY PHRASES

 24/25 Avoid contact with skin and eyes

 

PACKING

 

 

PRICE INFORMATION